IchorLabs

166 posts

IchorLabs banner
IchorLabs

IchorLabs

@Ichor_Labs

We provide game-changing technology for high-yield capture of circulating cell-free DNA/RNA.

Katılım Mayıs 2017
38 Takip Edilen23 Takipçiler
IchorLabs retweetledi
Exact Sciences
Exact Sciences@ExactSciences·
Cancer is a leading cause of death in the U.S. Learn more about the rigorous research we are doing to advance the development of earlier detection at #DDW19.
English
15
16
74
0
IchorLabs retweetledi
Inivata
Inivata@Inivata·
Don't miss 'Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer' being presented Thursday, February 28, 2019 @ASCO -SITC Clinical Immuno-Oncology Symposium program #liquidbiopsy #invision
English
0
2
3
0
IchorLabs
IchorLabs@Ichor_Labs·
GRAIL to Present New Data from Circulating Cell-free Genome Atlas (CCGA) Study at 2018 American Society of Clinical Oncology Annual Meeting | Business Wire businesswire.com/news/home/2018…
English
0
0
1
0
IchorLabs retweetledi
Front Line Genomics
Front Line Genomics@FLGenomics·
The FDA have finalised two guidances designed to enhance collaboration among researchers, and drive the efficient development of novel NGS-based tests. buff.ly/2vi24w6
English
0
6
3
0
IchorLabs
IchorLabs@Ichor_Labs·
GRAIL-Announces-Data-Prototype-Blood-Tests-Early#.WtaRRlgrjdE.twitter
English
0
0
0
0
IchorLabs retweetledi
Front Line Genomics
Front Line Genomics@FLGenomics·
The first study of its kind has found that genome sequencing didn’t significantly increase health-care spending in the short term. buff.ly/2pywTYc
English
0
7
8
0
IchorLabs retweetledi
ArcherDX, Inc.
ArcherDX, Inc.@archerdxinc·
"In general, we can say there is growing evidence in solid tumors, especially in lung tumors, that gene fusions comprise the main genetic driver in those tumors." -Dr. John Iafrate discussing new #NGS applications for targeted #cancer therapies #FusionPlex captodayonline.com/next-gen-seque…
English
0
1
0
0